相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Favorable overall survival in stage III melanoma patients after adjuvant dendritic cell vaccination
Kalijn F. Bol et al.
ONCOIMMUNOLOGY (2016)
Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity
Kalijn F. Bol et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial
Alexander M. M. Eggermont et al.
LANCET ONCOLOGY (2015)
Neo approaches to cancer vaccines
Lelia Delamarre et al.
SCIENCE (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
Beatriz M. Carreno et al.
SCIENCE (2015)
Intranodal vaccination with mRNA-optimized dendritic cells in metastatic melanoma patients
Kalijn F. Bol et al.
ONCOIMMUNOLOGY (2015)
Clinical use of dendritic cells for cancer therapy
Sebastien Anguille et al.
LANCET ONCOLOGY (2014)
Targeting CD4+ T-Helper Cells Improves the Induction of Antitumor Responses in Dendritic Cell-Based Vaccination
Erik H. J. G. Aarntzen et al.
CANCER RESEARCH (2013)
Dendritic-Cell-Based Therapeutic Cancer Vaccines
Karolina Palucka et al.
IMMUNITY (2013)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
International trends in the incidence of malignant melanoma 1953-2008uare recent generations at higher or lower risk?
Friederike Erdmann et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Challenges of Guarantee-Time Bias
Anita Giobbie-Hurder et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Humoral anti-KLH responses in cancer patients treated with dendritic cell-based immunotherapy are dictated by different vaccination parameters
Erik H. J. G. Aarntzen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Monocytic CCR2+ Myeloid-Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD8 T-cell Infiltration into the Tumor Microenvironment
Alexander M. Lesokhin et al.
CANCER RESEARCH (2012)
Skin-Test Infiltrating Lymphocytes Early Predict Clinical Outcome of Dendritic Cell-Based Vaccination in Metastatic Melanoma
Erik H. J. G. Aarntzen et al.
CANCER RESEARCH (2012)
Vaccination with mRNA-Electroporated Dendritic Cells Induces Robust Tumor Antigen-Specific CD4+ and CD8+ T Cells Responses in Stage III and IV Melanoma Patients
Erik H. J. G. Aarntzen et al.
CLINICAL CANCER RESEARCH (2012)
Cancer immunotherapy via dendritic cells
Karolina Palucka et al.
NATURE REVIEWS CANCER (2012)
Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used
W. Joost Lesterhuis et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Landmark Analysis at the 25-Year Landmark Point
Urania Dafni
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2011)
Route of Administration Modulates the Induction of Dendritic Cell Vaccine-Induced Antigen-Specific T Cells in Advanced Melanoma Patients
W. Joost Lesterhuis et al.
CLINICAL CANCER RESEARCH (2011)
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
Padmanee Sharma et al.
NATURE REVIEWS CANCER (2011)
Utility of adjuvant systemic therapy in melanoma
A. M. M. Eggermont et al.
ANNALS OF ONCOLOGY (2009)
In situ Expression of Tumor Antigens by Messenger RNA-Electroporated Dendritic Cells in Lymph Nodes of Melanoma Patients
Danita H. Schuurhuis et al.
CANCER RESEARCH (2009)
Final Version of 2009 AJCC Melanoma Staging and Classification
Charles M. Balch et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Morbidity and prognosis after therapeutic lymph node dissections for malignant melanoma
A. C. J. van Akkooi et al.
EJSO (2007)
Immune resistance orchestrated by the tumor microenvironment
Thomas F. Gajewski et al.
IMMUNOLOGICAL REVIEWS (2006)
Immunomonitoring tumor-specific T cells in delayed-type hypersensitivity skin biopsies after dendritic cell vaccination correlates with clinical outcome
IJM de Vries et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Dendritic cell immunotherapy: mapping the way
CG Figdor et al.
NATURE MEDICINE (2004)
Does adjuvant interferon-α for high-risk melanoma provide a worthwhile benefit?: A meta-analysis of the randomised trials
K Wheatley et al.
CANCER TREATMENT REVIEWS (2003)
Large-scale generation of mature monocyte-derived dendritic cells for clinical application in cell factories™
TG Berger et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
Epitope spreading in immunemediated diseases: Implications for immunotherapy
CL Vanderlugt et al.
NATURE REVIEWS IMMUNOLOGY (2002)
分享论文
